Validating wearable sensors as an assessment tool for Parkinson's disease.
Publication/Presentation Date
9-1-2026
Abstract
PURPOSE: The International Parkinson and Movement Disorder Society Modified Unified Parkinson's Disease Rating Scale (MDS-UPDRS) is the gold standard evaluation of Parkinson's Disease (PD), but there is inter-rater variability. Wearable biosensors are a novel tool to quantify neurodegenerative symptoms in PD. This project aimed to use XSens sensors to assess PD patients during motor tasks and identify differences compared to controls.
METHODS: Participants with PD (
RESULTS: Using XSens, we found stride length in PD patients is reduced compared to controls (0.58 m vs. 0.97 m,
CONCLUSION: We identified novel clinical tests of wrist rigidity and rhythmicity, which identified significant differences between groups. This exploratory study indicates accelerometry is a promising biomarker for remote monitoring and screening of PD, which needs to be substantiated with large-scale clinical studies.
Volume
48
Issue
19
First Page
6361
Last Page
6371
ISSN
1464-5165
Published In/Presented At
Silis, K., Kieran, N. W., Shawki, N., Madarshahian, S., Liang, T. W., & Serruya, M. (2026). Validating wearable sensors as an assessment tool for Parkinson's disease. Disability and rehabilitation, 48(19), 6361–6371. https://doi.org/10.1080/09638288.2026.2629784
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
41782386
Department(s)
Administration and Leadership
Document Type
Article